Corcept Therapeutics reported $1.25M in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
TG Therapeutics TGTX:US 237K 27K
Acadia Pharmaceuticals ACAD:US $ 2.95M 0.39M
Ani Pharmaceuticals ANIP:US $ 34.27M 373K
Ardelyx ARDX:US $ 0.08M 0.08M
Aurora Cannabis Inc ACB:CN 103.36M 6.41M
Biomarin Pharmaceutical BMRN:US $ 116.96M 2.78M
Bristol Myers Squibb BMY:US $ 2471M 115M
Canopy Growth Corp WEED:CN C$ 271.01M 140.13M
Corcept Therapeutics CORT:US $ 1.25M 0.1M
Depomed DEPO:US $ 4.2M 0.7M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Esperion Therapeutics ESPR:US $ 7.12M 2.05M
Johnson & Johnson JNJ:US $ 7598M 357M
Knight Therapeutics Inc GUD:CN C$ 31.33M 1.25M
Lannett LCI:US $ 75.28M 5.52M
Merk MRK:US $ 5334M 1507M
Nektar Therapeutics NKTR:US $ 5.32M 0.85M
Novartis NOVN:VX SF 3755M 245M
Novartis NVS:US $ 3755M 245M
Pacira Pharmaceuticals PCRX:US $ 36.07M 2.93M
Pfizer PFE:US $ 10010M 399M
Supernus Pharmaceuticals SUPN:US $ 17.93M 0.94M